Ana içeriğe geç
Lütfen telefonunuzu dik konuma getiriniz.

Yayınlar

  • Öztürk B, Taşkıran E, Demir S, Arat MM, Siva A, Ata N, Birinci Ş, Kürtüncü M. Real-world evidence from Türkiye on cancer risk and treatment exposure in multiple sclerosis: A histopathology-verified, registry-based study. Mult Scler Relat Disord. 2025 May 24;100:106547. doi: 10.1016/j.msard.2025.106547. Epub ahead of print. PMID: 40449191.
  • Taşkıran E, Öztürk B, Demir S, Ata N, Ülgü MM, Birinci Ş, Tuncer A, Kürtüncü M. Prevalence and incidence of neuromyelitis optica spectrum disorder in Türkiye: A nationwide epidemiologic study. Mult Scler Relat Disord. 2025 May;97:106383. doi: 10.1016/j.msard.2025.106383. Epub 2025 Mar 9. PMID: 40068231.
  • Seferoğlu M, Tunç A, Sıvacı AÖ, Uzuner GT, Mungan S, İnanç Y, Yetkin MF, Öztürk B, Koç ER, Türkoğlu ŞA, Aksoy S, Yurtoğulları Ş, Elçi Ö. Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study. Mult Scler Relat Disord. 2024 Dec;92:105939. doi: 10.1016/j.msard.2024.105939. Epub 2024 Oct 11. PMID: 39423725.
  • Yaşa, M. E., Sonkaya, R., Korkmaz, B., Fındık, B. N., et al. (2024). PARKİNSON HASTALARINDA HASTALIĞA ÖZGÜ YAŞAM KALİTESİNİ BELİRLEYEN MOTOR SEMPTOMLAR. İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi, 12(3), 1042-1055. https://doi.org/10.33715/inonusaglik.1499243
  • Inan B, Ozturk B, Ata N, Ulgu MM, Birinci S, Sonkaya R, Eroglu E, Karadas O, Tan E, Odabasi Z. A nationwide epidemiological study of myasthenia gravis in Turkey. J Neurol. 2024 Dec 12;272(1):5. doi: 10.1007/s00415-024-12781-8. PMID: 39666142.
  • Taşkıran ET and Öztürk BJCMJ. Neutrophil/lymphocyte ratio as an indicator of radiological disease activity in clinically stable multiple sclerosis. Cukurova Medical Journal, vol. 49, no. 3, 2024, pp. 721-7, doi:10.17826/cumj.1477602.
  • Öztürk B, Taşkıran E, Demir S, Tuncer MA, Kürtüncü M, Karabudak R, Siva A, Efendi H, Ata N, Ülgü MM, Birinci Ş. Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic study. Mult Scler. 2024 Jun;30(7):790-799. doi: 10.1177/13524585241245318. Epub 2024 Apr 14. PMID: 38616518.
  • Kurtuncu, M., Ozturk, B., Taskiran, E., Demir, S., Ata, N., Ulgu, M. M., ... Birinci, S.(2024). Survival of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Epidemiological Analysis in Turkiye. MULTIPLE SCLEROSIS JOURNAL , no.3, 780-781
  • Sonkaya ZZ, Özturk B, Sonkaya R, Taskiran E, Karadas Ö. Using Objective Speech Analysis Techniques for the Clinical Diagnosis and Assessment of Speech Disorders in Patients with Multiple Sclerosis. Brain Sci. 2024 Apr 16;14(4):384. doi: 10.3390/brainsci14040384. Erratum in: Brain Sci. 2024 Oct 14;14(10):1019. doi: 10.3390/brainsci14101019. PMID: 38672033; PMCID: PMC11047916.